Isracard came into this earnings release with a bruised share price. The stock is down about 28% over the past three months, despite the company reporting a 12 month period of profitability and trading on a P/E of 14.6x. The expectation gap is clear. The market has been treating Isracard like a problem story, while the latest quarter shows Basic EPS of ₪0.25 on revenue of ₪871m and net income of ₪80m. The core question now is how investors weigh that profit line against the company’s debt load and recent dilution.
Love that Isracard is still profitable but concerned about the recent share price slide and questions around balance sheet strength? Take a look at our screener of list of solid balance sheet and fundamentals stocks (434 results).
Q2 2026 Earnings Summary
- Revenue, Q2 2026 vs. Q2 2025: ₪871m vs. ₪817m (up about 6.6%)
- Net Income, Q2 2026 vs. Q2 2025: ₪80m vs. a loss of ₪150m (returned to profit)
- Basic EPS, Q2 2026 vs. Q2 2025: ₪0.25 vs. a loss of ₪0.74 per share (moved from loss to profit)
- Trailing 12-month Revenue, to Q2 2026 vs. to Q2 2025: ₪3,359m vs. ₪3,184m (up about 5.5%)
Prefer clean visuals instead of scrolling through dense earnings tables and raw figures? View Isracard’s full financial picture, including a clear look at its balance sheet strength, in the interactive company report for Isracard.
Isracard earnings lean toward a recovery story
For a payments and credit business like Isracard, the swing from a loss of ₪150m to net income of ₪80m on modest revenue growth to ₪871m points to a business that is still functioning as core infrastructure in Israeli digital payments. Basic EPS of ₪0.25, alongside higher trailing 12 month revenue of ₪3,359m, supports the idea that transaction driven activity is holding up. The abandoned Esh Bank deal also keeps capital tied to the existing franchise rather than to a new banking build out.
Weak share price keeps balance sheet questions alive
The share price is down about 28% over 90 days, which shows investors remain focused on risk even as Isracard returns to profit. The move from a sizeable loss to positive net income reduces immediate concern that the business model is structurally broken. However, the cancellation of the Esh Bank acquisition may feed a narrative that execution on new growth avenues is not straightforward. For now, trading pressure and earlier worries about debt and dilution still resonate more than one quarter of cleaner earnings.
After a year of dilution, high debt and large one off items, are these setbacks isolated or deeper structural issues? Review the risk analysis for Isracard which shows 4 important warning signsStay Ahead With Simply Wall St
If Isracard’s return to profit but weaker share price has your attention, register for free with Simply Wall St and add it to a Watchlist to track its price against fair value and watch for an entry point that fits your plan. After you decide to take a position, use the Portfolio Command Center to keep on top of essential updates while filtering out the daily noise. For a longer term view, tap into crowd insights and different angles on Isracard through the Community. This way you can spot potential catalysts and risks early and give yourself a better chance of staying ahead of the market.
Seeking Alternatives Beyond Isracard?
Some stocks are already building quiet momentum while others risk getting caught before a breakout even starts. Check fresh ideas that are still under the radar for now and consider them carefully.
- Identify companies that are already building quiet momentum before they attract wider attention by scanning the curated 296 resilient stocks with low risk scores.
- Review potential breakout candidates while prices still reflect caution by exploring the focused 608 high quality undiscovered gems.
- Find steady cash generators with strong income support and use the hand picked 438 dividend fortresses to guide your next shortlist.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com